Kwality Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled to be held on December 22, 2016, to consider the interim dividend for the financial year 2016-17. Further in accordance with the Company’s code of conduct for prevention of insider trading, the trading window will be closed with effect from December 13, 2016 till 48 hours from the conclusion of the meeting.
The above information is a part of company’s filings submitted to BSE.